Key result
Co-existing diabetes and hypertension in pregnancy markedly raises maternal and fetal complication risks.
Why the study?
Diabetes in pregnancy and hypertension in pregnancy are increasing conditions associated with significant maternal and fetal/neonatal morbidity and mortality.
Managing hypertension in diabetic pregnancies requires a delicate balance of controlling blood pressure and glucose levels to optimize fetomaternal outcomes, using safe agents like methyldopa and labetalol while avoiding teratogenic medications like ACE inhibitors and ARBs.
Last few decades have observed increase in Diabetes in pregnancy which may be attributed to urbanisation sedentary lifestyle, obesity, hypertension, prediabetes, alcohol consumption, and immigration. On the other hand hypertension in pregnancy in another significant condition resulting in substantial maternal and fetal/neonatal morbidity and mortality. It
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2019) conducted a review in Hypertension in Diabetic Pregnancy. Pharmacological management and lifestyle modifications was evaluated. Co-existence of diabetes and hypertension during pregnancy significantly increases maternal and fetal complications, necessitating careful pharmacological management and postpartum cardiovascular follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: